FDA commissioner discusses key policy goals for 2018

On December 14, 2017, the Commissioner of the U.S. Food and Drug Administration (“FDA”), Dr. Scott Gottlieb, posted Looking ahead: Some of FDA’s major policy goals for 2018 on FDA’s blog, FDA Voice, and discussed FDA’s policy agenda published on the Unified Agenda of Federal Regulatory and Deregulatory Actions (“Unified Agenda”), which provides the public with insight into regulations under development or review throughout the federal government. In the Unified Agenda, FDA outlines some of its efforts to modernize its approach and improve its efficiency, while protecting and promoting the public health and upholding FDA’s “gold standard” for regulatory decision-making. Gottlieb discussed FDA’s contributions to the Fall 2017 Unified Agenda, which address a number of areas of policymaking underway at the agency, and are directly aligned with FDA’s major priorities: Addressing the Nicotine Addiction Crisis:…

Read more detail on Recent Health Care Law posts –

This entry was posted in Health Law and tagged , , , , . Bookmark the permalink.

Leave a Reply